Status:

UNKNOWN

Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome

Lead Sponsor:

University of Sao Paulo General Hospital

Conditions:

Prader-Willi Syndrome

Eligibility:

All Genders

15+ years

Phase:

PHASE1

Brief Summary

The purpose of this study is to investigate the safety and efficacy of deep brain stimulation in obese patients with Prader Willi syndrome refractory to conventional treatment.

Detailed Description

The purpose of this study is to investigate the safety and efficacy of deep brain stimulation in obese patients with Prader Willi syndrome refractory to conventional treatment. Patients will be implan...

Eligibility Criteria

Inclusion

  • 15 years or older
  • Parents able to give informed consent
  • Diagnosis of Prader-Willi syndrome confirmed by genetic analysis
  • Refractoriness to medical treatment, defined as a weight loss lower than 10% of the body weight with nutritional, pharmacological or surgical interventions
  • Severe or morbid obesity
  • No contra-indications to the surgical procedure

Exclusion

  • Cardiovascular disease that might significantly increase the surgical risk
  • Brain lesions detected clinically or during MRI
  • Use of cardiac pacemakers/ defibrillators
  • Clinical conditions that may require the use of MRI in the post-operative period
  • Patients undergoing chemotherapy or immunosuppressive treatments
  • Patients unable to return to the hospital at the required intervals
  • Previous neurosurgical treatments that may increase the risk of DBS surgery
  • Active medical conditions that may require in-hospital treatment in the nearby future
  • Previous diagnosis of epilepsy or status epilepticus
  • Chronic infection
  • Plan to use diathermy
  • Metallic implants that might preclude MRI imaging of the brain
  • Active participation in other experimental studies

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2016

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT02297022

Start Date

October 1 2014

End Date

October 1 2016

Last Update

December 16 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

HCFUMSP

São Paulo, São Paulo, Brazil, 0543-010